ANCN

Anchiano Therapeutics (ANCN)

Anchiano Therapeutics Ltd

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:ANCN

1 2 3 4 5 6 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2023/06/17	05 : 02	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ANCN	Anchiano Therapeutics Ltd
2023/06/05	20 : 01	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ANCN	Anchiano Therapeutics Ltd
2023/05/20	05 : 07	Edgar (US Regulatory)	Securities Registration Statement (s-1/a)	NASDAQ:ANCN	Anchiano Therapeutics Ltd
2023/05/11	19 : 08	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:ANCN	Anchiano Therapeutics Ltd
2023/03/23	20 : 37	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ANCN	Anchiano Therapeutics Ltd
2023/03/23	20 : 36	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ANCN	Anchiano Therapeutics Ltd
2023/03/23	20 : 34	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ANCN	Anchiano Therapeutics Ltd
2023/03/23	05 : 46	Edgar (US Regulatory)	Securities Registration Statement (s-1/a)	NASDAQ:ANCN	Anchiano Therapeutics Ltd
2023/02/21	21 : 06	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ANCN	Anchiano Therapeutics Ltd
2023/02/21	20 : 20	Edgar (US Regulatory)	Securities Registration Statement (s-1/a)	NASDAQ:ANCN	Anchiano Therapeutics Ltd
2023/01/12	06 : 02	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ANCN	Anchiano Therapeutics Ltd
2023/01/06	06 : 50	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ANCN	Anchiano Therapeutics Ltd
2023/01/06	06 : 02	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ANCN	Anchiano Therapeutics Ltd
2023/01/03	21 : 06	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ANCN	Anchiano Therapeutics Ltd
2022/11/29	20 : 17	Edgar (US Regulatory)	Amended Current Report Filing (8-k/a)	NASDAQ:ANCN	Anchiano Therapeutics Ltd
2022/11/18	21 : 54	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ANCN	Anchiano Therapeutics Ltd
2022/11/18	06 : 57	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ANCN	Anchiano Therapeutics Ltd
2022/11/16	21 : 21	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ANCN	Anchiano Therapeutics Ltd
2022/11/16	06 : 04	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:ANCN	Anchiano Therapeutics Ltd
2022/11/15	06 : 11	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ANCN	Anchiano Therapeutics Ltd
2022/11/11	06 : 13	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:ANCN	Anchiano Therapeutics Ltd
2022/08/16	05 : 07	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	NASDAQ:ANCN	Anchiano Therapeutics Ltd
2022/08/12	20 : 08	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ANCN	Anchiano Therapeutics Ltd
2022/06/21	20 : 01	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ANCN	Anchiano Therapeutics Ltd
2022/06/08	19 : 03	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ANCN	Anchiano Therapeutics Ltd
2022/05/31	23 : 31	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:ANCN	Anchiano Therapeutics Ltd
2022/05/26	05 : 04	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ANCN	Anchiano Therapeutics Ltd
2022/05/20	05 : 03	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ANCN	Anchiano Therapeutics Ltd
2022/05/12	19 : 21	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ANCN	Anchiano Therapeutics Ltd
2022/04/29	05 : 07	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:ANCN	Anchiano Therapeutics Ltd